Vanda Pharmaceuticals Inc. (VNDA) stock saw a decline, ending the day at $4.94 which represents a decrease of $-0.14 or -2.76% from the prior close of $5.08. The stock opened at $5.12 and touched a ...
(RTTNews) - Vanda Pharmaceuticals (VNDA) said, on September 18, the FDA declined to approve New Drug Application of tradipitant for the treatment of symptoms in gastroparesis, providing the company ...
What's Going On With Vanda Pharmaceuticals Shares Today? Vanda Pharmaceuticals shares decline as Future Pak withdraws acquisition offer following Vanda's rejection and lack of response.